Metabolic disorders represent significant public health challenges worldwide. Emerging evidence suggests that cytokines and microRNAs (miRNAs) play crucial roles in the pathogenesis of metabolic disorders by regulating various metabolic processes, including insulin sensitivity, lipid metabolism, and inflammation. This review provides a comprehensive overview of the intricate interplay between cytokines and miRNAs in the context of metabolic disorders, including obesity, type 2 diabetes, and cardiovascular diseases. We discuss how dysregulation of cytokine–miRNA networks contributes to the development and progression of metabolic disorders and explore the therapeutic potential of targeting these interactions for disease management.
Get full access to this article
View all access options for this article.
References
1.
AbonnencM, NabeebaccusAA, MayrU, et al.Extracellular matrix secretion by cardiac fibroblasts: Role of microRNA-29b and microRNA-30c. Circ Res, 2013; 113(10):1138–1147; doi: 10.1161/CIRCRESAHA.113.302400
2.
AfonsoMS, VermaN, van SolingenC, et al.MicroRNA-33 inhibits adaptive thermogenesis and adipose tissue beiging. Arterioscler Thromb Vasc Biol, 2021; 41(4):1360–1373; doi: 10.1161/ATVBAHA.120.315798
3.
AkbariM, Hassan-ZadehV. IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology, 2018; 26(3):685–698; doi: 10.1007/s10787-018-0458-0
4.
AliAM, El-TawilOS, Al-MokaddemAK, et al.Promoted inhibition of TLR4/miR-155/NF(k)B p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide. Chem Biol Interact, 2021; 336:109398; doi: 10.1016/j.cbi.2021.109398
5.
AliqueM, BodegaG, GiannarelliC, et al.MicroRNA-126 regulates hypoxia-inducible factor-1alpha which inhibited migration, proliferation, and angiogenesis in replicative endothelial senescence. Sci Rep, 2019; 9(1):7381; doi: 10.1038/s41598-019-43689-3
6.
AminMN, SiddiquiSA, IbrahimM, et al.Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer. SAGE Open Med, 2020; 8:2050312120965752; doi: 10.1177/2050312120965752
BaldeonRL, WeigeltK, de WitH, et al.Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients. PLoS One, 2014; 9(12):e115209; doi: 10.1371/journal.pone.0115209
9.
BarrosoI, McCarthyMI. The genetic basis of metabolic disease. Cell, 2019; 177(1):146–161; doi: 10.1016/j.cell.2019.02.024
10.
BejeranoT, EtzionS, ElyagonS, et al.Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction. Nano Lett, 2018; 18(9):5885–5891; doi: 10.1021/acs.nanolett.8b02578
11.
BonauerA, CarmonaG, IwasakiM, et al.MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Sci, 2009; 324(5935):1710–1713; doi: 10.1126/science.1174381
12.
BruenR, FitzsimonsS, BeltonO. miR-155 in the resolution of atherosclerosis. Front Pharmacol, 2019; 10:463; doi: 10.3389/fphar.2019.00463
13.
CallisTE, PandyaK, SeokHY, et al.MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest, 2009; 119(9):2772–2786; doi: 10.1172/JCI36154
14.
CaloN, RamadoriP, SobolewskiC, et al.Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption. Gut, 2016; 65(11):1871–1881; doi: 10.1136/gutjnl-2015-310822
15.
CaoY, CaoZ, WangW, et al.MicroRNA-199-5p regulates FOXC2 to control human vascular smooth muscle cell phenotypic switch. Mol Med Rep, 2021; 24(3); doi: 10.3892/mmr.2021.12266
16.
CaoRY, LiQ, MiaoY, et al.The emerging role of MicroRNA-155 in cardiovascular diseases. Biomed Res Int, 2016; 2016:9869208; doi: 10.1155/2016/9869208
17.
CaoX, LuB, GuY, et al.miR-210-3p impairs pancreatic beta-cell function by targeting Dtx1 in gestational diabetes mellitus. J Environ Pathol Toxicol Oncol, 2022; 41(4):11–23; doi: 10.1615/JEnvironPatholToxicolOncol.2022041670
18.
CaoD, MikoszAM, RingsbyAJ, et al.MicroRNA-126-3p inhibits angiogenic function of human lung microvascular endothelial cells via LAT1 (L-Type Amino Acid Transporter 1)-mediated mTOR (Mammalian Target of Rapamycin) signaling. Arterioscler Thromb Vasc Biol, 2020; 40(5):1195–1206; doi: 10.1161/ATVBAHA.119.313800
19.
ChakrabortyC, SharmaAR, SharmaG, et al.The Interplay among miRNAs, major cytokines, and cancer-related inflammation. Mol Ther Nucleic Acids, 2020; 20:606–620; doi: 10.1016/j.omtn.2020.04.002
20.
ChenWJ, YinK, ZhaoGJ, et al.The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis, 2012; 222(2):314–323; doi: 10.1016/j.atherosclerosis.2012.01.020
21.
ChengQ, McKeownSJ, SantosL, et al.Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J Immunol, 2010; 185(2):1238–1247; doi: 10.4049/jimmunol.0904104
22.
ChengJ, WangY, WangD, et al.Identification of collagen 1 as a post-transcriptional target of miR-29b in skin fibroblasts: Therapeutic implication for scar reduction. Am J Med Sci, 2013; 346(2):98–103; doi: 10.1097/MAJ.0b013e318267680d
23.
Clemente-SuarezVJ, Martin-RodriguezA, Redondo-FlorezL, et al.New Insights and Potential Therapeutic Interventions in Metabolic Diseases. Int J Mol Sci, 2023a;24(13); doi: 10.3390/ijms241310672
24.
Clemente-SuarezVJ, Redondo-FlorezL, Beltran-VelascoAI, et al.The role of adipokines in health and disease. Biomedicines, 2023b;11(5); doi: 10.3390/biomedicines11051290
25.
CornejoPJ, VergoniB, OhannaM, et al.The stress-responsive microRNA-34a alters insulin signaling and actions in adipocytes through induction of the tyrosine phosphatase PTP1B. Cells, 2022; 11(16); doi: 10.3390/cells11162581
26.
Corral-FernandezNE, Salgado-BustamanteM, Martinez-LeijaME, et al.Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes. Exp Clin Endocrinol Diabetes, 2013; 121(6):347–353; doi: 10.1055/s-0033-1341516
27.
DavalosA, GoedekeL, SmibertP, et al.miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A, 2011; 108(22):9232–9237; doi: 10.1073/pnas.1102281108
28.
DuW, LiangH, GaoX, et al.MicroRNA-328, a potential anti-fibrotic target in cardiac interstitial fibrosis. Cell Physiol Biochem, 2016; 39(3):827–836; doi: 10.1159/000447793
29.
FrangogiannisNG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol, 2014; 11(5):255–265; doi: 10.1038/nrcardio.2014.28
30.
GhiasiSM, DahllofMS, OsmaiY, et al.Regulation of the beta-cell inflammasome and contribution to stress-induced cellular dysfunction and apoptosis. Mol Cell Endocrinol, 2018; 478:106–114; doi: 10.1016/j.mce.2018.08.001
31.
GuX, WangL, LiuS, et al.Adipose tissue adipokines and lipokines: Functions and regulatory mechanism in skeletal muscle development and homeostasis. Metabolism, 2023; 139:155379; doi: 10.1016/j.metabol.2022.155379
32.
GuanY, SongX, SunW, et al.Effect of hypoxia-induced MicroRNA-210 expression on cardiovascular disease and the underlying mechanism. Oxid Med Cell Longev, 2019; 2019:4727283; doi: 10.1155/2019/4727283
33.
GuoJ, MeiH, ShengZ, et al.Hsa-miRNA-23a-3p promotes atherogenesis in a novel mouse model of atherosclerosis. J Lipid Res, 2020; 61(12):1764–1775; doi: 10.1194/jlr.RA120001121
34.
HeF, LiuY, LiT, et al.MicroRNA-146 attenuates lipopolysaccharide induced ovarian dysfunction by inhibiting the TLR4/NF-kappaB signaling pathway. Bioengineered, 2022; 13(5):11611–11623; doi: 10.1080/21655979.2022.2070584
35.
HeneinMY, VancheriS, LongoG, et al.The role of inflammation in cardiovascular disease. Int J Mol Sci, 2022; 23(21); doi: 10.3390/ijms232112906
36.
HouJ, DengQ, DengX, et al.MicroRNA-146a-5p alleviates lipopolysaccharide-induced NLRP3 inflammasome injury and pro-inflammatory cytokine production via the regulation of TRAF6 and IRAK1 in human umbilical vein endothelial cells (HUVECs). Ann Transl Med, 2021; 9(18):1433; doi: 10.21037/atm-21-3903
37.
HuY, DuG, LiG, et al.The miR-122 inhibition alleviates lipid accumulation and inflammation in NAFLD cell model. Arch Physiol Biochem, 2021; 127(5):385–389; doi: 10.1080/13813455.2019.1640744
38.
HuX, TangJ, HuX, et al.MiR-27b impairs adipocyte differentiation of human adipose tissue-derived mesenchymal stem cells by targeting LPL. Cell Physiol Biochem, 2018; 47(2):545–555; doi: 10.1159/000489988
39.
HuangN, WangJ, XieW, et al.MiR-378a-3p enhances adipogenesis by targeting mitogen-activated protein kinase 1. Biochem Biophys Res Commun, 2015; 457(1):37–42; doi: 10.1016/j.bbrc.2014.12.055
40.
IshidaM, ShimabukuroM, YagiS, et al.MicroRNA-378 regulates adiponectin expression in adipose tissue: A new plausible mechanism. PLoS One, 2014; 9(11):e111537; doi: 10.1371/journal.pone.0111537
41.
JankauskasSS, GambardellaJ, SarduC, et al.Functional role of miR-155 in the pathogenesis of diabetes mellitus and its complications. Noncoding RNA, 2021; 7(3); doi: 10.3390/ncrna7030039
42.
JansenF, StumpfT, ProebstingS, et al.Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6. J Mol Cell Cardiol, 2017; 104:43–52; doi: 10.1016/j.yjmcc.2016.12.005
43.
JimenezA, Organista-JuarezD, Torres-CastroA, et al.Olfactory dysfunction in diabetic rats is associated with miR-146a overexpression and inflammation. Neurochem Res, 2020; 45(8):1781–1790; doi: 10.1007/s11064-020-03041-y
44.
JohnsonC, DrummerC, VirtueA, et al.Increased expression of resistin in MicroRNA-155-deficient white adipose tissues may be a possible driver of metabolically healthy obesity transition to classical obesity. Front Physiol, 2018; 9:1297; doi: 10.3389/fphys.2018.01297
45.
KabekkoduSP, ShuklaV, VargheseVK, et al.Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc, 2018; 93(4):1955–1986; doi: 10.1111/brv.12428
46.
KangM, YanLM, ZhangWY, et al.Role of microRNA-21 in regulating 3T3-L1 adipocyte differentiation and adiponectin expression. Mol Biol Rep, 2013; 40(8):5027–5034; doi: 10.1007/s11033-013-2603-6
47.
KanyS, VollrathJT, ReljaB. Cytokines in inflammatory disease. Int J Mol Sci, 2019; 20(23); doi: 10.3390/ijms20236008
48.
KaribaY, YoshizawaT, SatoY, et al.Brown adipocyte-derived exosomal miR-132-3p suppress hepatic Srebf1 expression and thereby attenuate expression of lipogenic genes. Biochem Biophys Res Commun, 2020; 530(3):500–507; doi: 10.1016/j.bbrc.2020.05.090
49.
KarkeniE, AstierJ, TourniaireF, et al.Obesity-associated inflammation induces microRNA-155 expression in adipocytes and adipose tissue: Outcome on adipocyte function. J Clin Endocrinol Metab, 2016; 101(4):1615–1626; doi: 10.1210/jc.2015-3410
50.
KawaiT, AutieriMV, ScaliaR. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol, 2021; 320(3):C375–C391; doi: 10.1152/ajpcell.00379.2020
51.
KeX, LiaoZ, LuoX, et al.Endothelial colony-forming cell-derived exosomal miR-21-5p regulates autophagic flux to promote vascular endothelial repair by inhibiting SIPL1A2 in atherosclerosis. Cell Commun Signal, 2022; 20(1):30; doi: 10.1186/s12964-022-00828-0
52.
KimYJ, HwangSJ, BaeYC, et al.MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells, 2009; 27(12):3093–3102; doi: 10.1002/stem.235
53.
KimSY, KimAY, LeeHW, et al.miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun, 2010; 392(3):323–328; doi: 10.1016/j.bbrc.2010.01.012
54.
KirichenkoTV, MarkinaYV, BogatyrevaAI, et al.The role of adipokines in inflammatory mechanisms of obesity. Int J Mol Sci, 2022; 23(23); doi: 10.3390/ijms232314982
55.
KohEH, ChernisN, SahaPK, et al.miR-30a remodels subcutaneous adipose tissue inflammation to improve insulin sensitivity in obesity. Diabetes, 2018; 67(12):2541–2553; doi: 10.2337/db17-1378
56.
LandrierJF, DerghalA, MounienL. MicroRNAs in obesity and related metabolic disorders. Cells, 2019; 8(8); doi: 10.3390/cells8080859
57.
LeeH, JeeY, HongK, et al.MicroRNA-494, upregulated by tumor necrosis factor-alpha, desensitizes insulin effect in C2C12 muscle cells. PLoS One, 2013; 8(12):e83471; doi: 10.1371/journal.pone.0083471
58.
LiJH, DaiJ, HanB, et al.MiR-34a regulates cell apoptosis after myocardial infarction in rats through the Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci, 2019; 23(6):2555–2562; doi: 10.26355/eurrev_201903_17404
59.
LiB, HuangX, YangC, et al.miR-27a regulates sheep adipocyte differentiation by targeting CPT1B gene. Animals (Basel), 2021; 12(1); doi: 10.3390/ani12010028
60.
LiX, WangJ, JiaZ, et al.MiR-499 regulates cell proliferation and apoptosis during late-stage cardiac differentiation via Sox6 and cyclin D1. PLoS One, 2013; 8(9):e74504; doi: 10.1371/journal.pone.0074504
61.
LiP, YinYL, GuoT, et al.Inhibition of aberrant MicroRNA-133a expression in endothelial cells by statin prevents endothelial dysfunction by targeting GTP Cyclohydrolase 1 in Vivo. Circulation, 2016; 134(22):1752–1765; doi: 10.1161/CIRCULATIONAHA.116.017949
62.
LiN, ZhouH, TangQ. miR-133: A suppressor of cardiac remodeling? Front Pharmacol, 2018; 9:903; doi: 10.3389/fphar.2018.00903
63.
LiangS, HuJ, ZhangA, et al.miR-155 induces endothelial cell apoptosis and inflammatory response in atherosclerosis by regulating Bmal1. Exp Ther Med, 2020; 20(6):128; doi: 10.3892/etm.2020.9259
64.
LiaoZ, ChenY, DuanC, et al.Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction. Theranostics, 2021; 11(1):268–291; doi: 10.7150/thno.47021
Lopez-PastorAR, Infante-MenendezJ, EscribanoO, et al.miRNA dysregulation in the development of non-alcoholic fatty liver disease and the related disorders type 2 diabetes mellitus and cardiovascular disease. Front Med (Lausanne), 2020; 7:527059; doi: 10.3389/fmed.2020.527059
67.
MahdaviR, GhorbaniS, AlipoorB, et al.Decreased serum level of miR-155 is associated with obesity and its related metabolic traits. Clin Lab, 2018; 64(1):77–84; doi: 10.7754/Clin.Lab.2017.170618
68.
Marques-RochaJL, SamblasM, MilagroFI, et al.Noncoding RNAs, cytokines, and inflammation-related diseases. Faseb J, 2015; 29(9):3595–3611; doi: 10.1096/fj.14-260323
69.
MartinelliR, NardelliC, PiloneV, et al.miR-519d overexpression is associated with human obesity. Obesity (Silver Spring), 2010; 18(11):2170–2176; doi: 10.1038/oby.2009.474
70.
MeersonA, TraurigM, OssowskiV, et al.Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-alpha. Diabetologia, 2013; 56(9):1971–1979; doi: 10.1007/s00125-013-2950-9
71.
MuralimanoharanS, GuoC, MyattL, et al.Sexual dimorphism in miR-210 expression and mitochondrial dysfunction in the placenta with maternal obesity. Int J Obes (Lond), 2015; 39(8):1274–1281; doi: 10.1038/ijo.2015.45
72.
NakanishiN, NakagawaY, TokushigeN, et al.The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun, 2009; 385(4):492–496; doi: 10.1016/j.bbrc.2009.05.058
73.
NarazakiM, KishimotoT. The two-faced Cytokine IL-6 in host defense and diseases. Int J Mol Sci, 2018; 19(11); doi: 10.3390/ijms19113528
74.
NematiM, AksehS, AmiriM, et al.Lactoferrin suppresses LPS-induced expression of HMGB1, microRNA 155, 146, and TLR4/MyD88/NF-small ka, CyrillicB pathway in RAW264.7 cells. Immunopharmacol Immunotoxicol, 2021; 43(2):153–159; doi: 10.1080/08923973.2021.1872616
75.
NiY, XuZ, LiC, et al.Therapeutic inhibition of miR-802 protects against obesity through AMPK-mediated regulation of hepatic lipid metabolism. Theranostics, 2021; 11(3):1079–1099; doi: 10.7150/thno.49354
76.
O’BrienJ, HayderH, ZayedY, et al.Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne), 2018; 9:402; doi: 10.3389/fendo.2018.00402
77.
OikawaS, WadaS, LeeM, et al.Role of endothelial microRNA-23 clusters in angiogenesis in vivo. Am J Physiol Heart Circ Physiol, 2018; 315(4):H838–H846; doi: 10.1152/ajpheart.00742.2017
78.
PanD, MaoC, QuattrochiB, et al.MicroRNA-378 controls classical brown fat expansion to counteract obesity. Nat Commun, 2014; 5:4725; doi: 10.1038/ncomms5725
79.
PriceNL, SinghAK, RotllanN, et al.Genetic ablation of miR-33 increases food intake, enhances adipose tissue expansion, and promotes obesity and insulin resistance. Cell Rep, 2018; 22(8):2133–2145; doi: 10.1016/j.celrep.2018.01.074
80.
QiaoY, WangC, KouJ, et al.MicroRNA-23a suppresses the apoptosis of inflammatory macrophages and foam cells in atherogenesis by targeting HSP90. Gene, 2020; 729:144319; doi: 10.1016/j.gene.2019.144319
81.
RasoulinejadSA, AkbariA, NasiriK. Interaction of miR-146a-5p with oxidative stress and inflammation in complications of type 2 diabetes mellitus in male rats: Anti-oxidant and anti-inflammatory protection strategies in type 2 diabetic retinopathy. Iran J Basic Med Sci, 2021; 24(8):1078–1086; doi: 10.22038/IJBMS.2021.56958.12706
82.
RaynerKJ, SuarezY, DavalosA, et al.MiR-33 contributes to the regulation of cholesterol homeostasis. Science, 2010; 328(5985):1570–1573; doi: 10.1126/science.1189862
83.
RoosJ, EnlundE, FunckeJB, et al.miR-146a-mediated suppression of the inflammatory response in human adipocytes. Sci Rep, 2016; 6:38339; doi: 10.1038/srep38339
84.
RuiL, AguirreV, KimJK, et al.Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest, 2001; 107(2):181–189; doi: 10.1172/JCI10934
85.
SarmaS, SockalingamS, DashS. Obesity as a multisystem disease: Trends in obesity rates and obesity-related complications. Diabetes Obes Metab, 2021; 23 Suppl 1:3–16; doi: 10.1111/dom.14290
86.
SessaF, SalernoM, EspositoM, et al.miRNA dysregulation in cardiovascular diseases: Current opinion and future perspectives. Int J Mol Sci, 2023; 24(6); doi: 10.3390/ijms24065192
87.
ShenZ, YuY, YangY, et al.miR-25 and miR-92b regulate insulin biosynthesis and pancreatic beta-cell apoptosis. Endocrine, 2022; 76(3):526–535; doi: 10.1007/s12020-022-03016-9
88.
ShiC, ZhuL, ChenX, et al.IL-6 and TNF-alpha induced obesity-related inflammatory response through transcriptional regulation of miR-146b. J Interferon Cytokine Res, 2014; 34(5):342–348; doi: 10.1089/jir.2013.0078
89.
SluijterJP, van MilA, van VlietP, et al.MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol, 2010; 30(4):859–868; doi: 10.1161/ATVBAHA.109.197434
90.
SoplinskaA, ZarebaL, WicikZ, et al.MicroRNAs as biomarkers of systemic changes in response to endurance exercise-a comprehensive review. Diagnostics (Basel), 2020; 10(10); doi: 10.3390/diagnostics10100813
91.
SuD, LiuH, QiX, et al.Citrus peel flavonoids improve lipid metabolism by inhibiting miR-33 and miR-122 expression in HepG2 cells. Biosci Biotechnol Biochem, 2019; 83(9):1747–1755; doi: 10.1080/09168451.2019.1608807
92.
SuG, SunG, LiuH, et al.Downregulation of miR-34a promotes endothelial cell growth and suppresses apoptosis in atherosclerosis by regulating Bcl-2. Heart Vessels, 2018; 33(10):1185–1194; doi: 10.1007/s00380-018-1169-6
93.
SunD, ChenJ, WuW, et al.MiR-802 causes nephropathy by suppressing NF-kappaB-repressing factor in obese mice and human. J Cell Mol Med, 2019; 23(4):2863–2871; doi: 10.1111/jcmm.14193
94.
SunL, TrajkovskiM. MiR-27 orchestrates the transcriptional regulation of brown adipogenesis. Metabolism, 2014; 63(2):272–282; doi: 10.1016/j.metabol.2013.10.004
95.
TrajkovskiM, HausserJ, SoutschekJ, et al.MicroRNAs 103 and 107 regulate insulin sensitivity. Nature, 2011; 474(7353):649–653; doi: 10.1038/nature10112
96.
TsalamandrisS, AntonopoulosAS, OikonomouE, et al.The role of inflammation in diabetes: Current concepts and future perspectives. Eur Cardiol, 2019; 14(1):50–59; doi: 10.15420/ecr.2018.33.1
97.
UnamunoX, Gomez-AmbrosiJ, RodriguezA, et al.Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest, 2018; 48(9):e12997; doi: 10.1111/eci.12997
98.
VezzaT, de MaranonAM, CanetF, et al.MicroRNAs and oxidative stress: An intriguing crosstalk to be exploited in the management of Type 2 diabetes. Antioxidants (Basel), 2021; 10(5); doi: 10.3390/antiox10050802
99.
WangR, HongJ, CaoY, et al.Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults. Eur J Endocrinol, 2015; 172(3):291–300; doi: 10.1530/EJE-14-0867
100.
WangJ, LiewOW, RichardsAM, et al.Overview of microRNAs in cardiac hypertrophy, fibrosis, and apoptosis. Int J Mol Sci, 2016; 17(5); doi: 10.3390/ijms17050749
101.
WangL, LiuWX, HuangXG. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy. Exp Mol Pathol, 2020; 116:104488; doi: 10.1016/j.yexmp.2020.104488
102.
WijesekaraN, ZhangLH, KangMH, et al.miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes, 2012; 61(3):653–658; doi: 10.2337/db11-0944
103.
WuH, PulaT, TewsD, et al.microRNA-27a-3p but not -5p is a crucial mediator of human adipogenesis. Cells, 2021a;10(11); doi: 10.3390/cells10113205
104.
WuGY, RuiC, ChenJQ, et al.MicroRNA-122 inhibits lipid droplet formation and hepatic triglyceride accumulation via Yin Yang 1. Cell Physiol Biochem, 2017; 44(4):1651–1664; doi: 10.1159/000485765
105.
WuD, XiQY, ChengX, et al.miR-146a-5p inhibits TNF-alpha-induced adipogenesis via targeting insulin receptor in primary porcine adipocytes. J Lipid Res, 2016; 57(8):1360–1372; doi: 10.1194/jlr.M062497
106.
WuW, XuK, LiM, et al.MicroRNA-29b/29c targeting CTRP6 influences porcine adipogenesis via the AKT/PKA/MAPK Signalling pathway. Adipocyte, 2021b;10(1):264–274; doi: 10.1080/21623945.2021.1917811
107.
XuK, ChenC, WuY, et al.Advances in miR-132-based biomarker and therapeutic potential in the cardiovascular system. Front Pharmacol, 2021; 12:751487; doi: 10.3389/fphar.2021.751487
108.
XuLL, ShiCM, XuGF, et al.TNF-alpha, IL-6, and leptin increase the expression of miR-378, an adipogenesis-related microRNA in human adipocytes. Cell Biochem Biophys, 2014; 70(2):771–776; doi: 10.1007/s12013-014-9980-x
109.
YamanSO, OremA, YucesanFB, et al.Evaluation of circulating miR-122, miR-30c and miR-33a levels and their association with lipids, lipoproteins in postprandial lipemia. Life Sci, 2021; 264:118585; doi: 10.1016/j.lfs.2020.118585
110.
YangD, WanX, SchwietermanN, et al.MicroRNA-1 deficiency is a primary etiological factor disrupting cardiac contractility and electrophysiological homeostasis. Circ Arrhythm Electrophysiol, 2024; 17(1):e012150; doi: 10.1161/CIRCEP.123.012150
111.
YeJ, GuoR, ShiY, et al.miR-155 regulated inflammation response by the SOCS1-STAT3-PDCD4 axis in atherogenesis. Mediators Inflamm, 2016; 2016:8060182; doi: 10.1155/2016/8060182
112.
ZatteraleF, LongoM, NaderiJ, et al.Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol, 2019; 10:1607; doi: 10.3389/fphys.2019.01607
113.
ZeinaliF, Aghaei ZarchSM, Jahan-MihanA, et al.Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study. PLoS One, 2021; 16(6):e0251697; doi: 10.1371/journal.pone.0251697
114.
ZhangJ, GaoZ, YinJ, et al.S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2. J Biol Chem, 2008; 283(51):35375–35382; doi: 10.1074/jbc.M806480200
115.
ZhangH, JiangY, ZhuS, et al.MiR-155-5p improves the insulin sensitivity of trophoblasts by targeting CEBPB in gestational diabetes mellitus. Placenta, 2024; 148:1–11; doi: 10.1016/j.placenta.2024.01.011
116.
ZhangY, LiC, LiH, et al.miR-378 activates the Pyruvate-PEP futile cycle and enhances lipolysis to ameliorate obesity in mice. EBioMedicine, 2016a;5:93–104; doi: 10.1016/j.ebiom.2016.01.035
117.
ZhangP, LiX, ZhangS, et al.miR-370-3p Regulates adipogenesis through targeting Mknk1. Molecules, 2021a;26(22); doi: 10.3390/molecules26226926
118.
ZhangY, MeiH, ChangX, et al.Adipocyte-derived microvesicles from obese mice induce M1 macrophage phenotype through secreted miR-155. J Mol Cell Biol, 2016b;8(6):505–517; doi: 10.1093/jmcb/mjw040
119.
ZhangY, YuanB, XuY, et al.MiR-208b/miR-21 promotes the progression of cardiac fibrosis through the activation of the TGF-beta1/Smad-3 signaling pathway: An in vitro and in vivo study. Front Cardiovasc Med, 2022; 9:924629; doi: 10.3389/fcvm.2022.924629
120.
ZhangXL, ZhangG, BaiZH. miR-34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin-1. Cell Biol Int, 2021b;45(3):642–653; doi: 10.1002/cbin.11512
121.
ZhangN, ZhangN, SongL, et al.Adipokines and free fatty acids regulate insulin sensitivity by increasing microRNA-21 expression in human mature adipocytes. Mol Med Rep, 2017; 16(2):2254–2258; doi: 10.3892/mmr.2017.6769
122.
ZhaoJ, HuL, GuiW, et al.Hepatocyte TGF-beta signaling inhibiting WAT browning to promote NAFLD and obesity is associated with Let-7b-5p. Hepatol Commun, 2022; 6(6):1301–1321; doi: 10.1002/hep4.1892
